FDA.reportPublic FDA data

repaglinide 2 MG Oral Tablet

RxCUI
200258
RxNorm name
repaglinide 2 MG Oral Tablet
Display name
repaglinide 2 MG Oral Tablet
Full name
repaglinide 2 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RepaglinideREPAGLINIDENorthStar RxLLC7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b6652025-09-15Warnings, Adverse reactionsExact identifier
rxcui: 200258
RepaglinideREPAGLINIDEBryant Ranch Prepackd85abce4-16da-4231-b28a-6afca04ebf682025-06-05Warnings, Adverse reactionsExact identifier
rxcui: 200258
RepaglinideREPAGLINIDEChartwell RX, LLCcb995e92-295e-4638-a064-978211f5afe12025-05-02Warnings, Adverse reactionsExact identifier
rxcui: 200258
RepaglinideREPAGLINIDEAurobindo Pharma Limited68064989-47ea-4ed5-a20e-43c4ef6ec2712024-05-14Warnings, Adverse reactionsExact identifier
rxcui: 200258
RepaglinideREPAGLINIDERising Pharma Holdings, Inc.d7673e22-0dbb-4395-ad60-943d249203a12024-05-14Warnings, Adverse reactionsExact identifier
rxcui: 200258
RepaglinideREPAGLINIDEMacleods Pharmaceuticals Limited7a93246c-9323-40c4-b590-a40dcb133c8c2023-04-04Warnings, Adverse reactionsExact identifier
rxcui: 200258

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 7 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
68064989-47ea-4ed5-a20e-43c4ef6ec271repaglinide 2 MG Oral Tablet [PSN] · repaglinide 2 MG Oral Tablet [SCD]211These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720240514
d7673e22-0dbb-4395-ad60-943d249203a1repaglinide 2 MG Oral Tablet [PSN] · repaglinide 2 MG Oral Tablet [SCD]27These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720240514
034c35a5-c037-4ad8-82d1-aec4feac4c97repaglinide 2 MG Oral Tablet [PSN] · repaglinide 2 MG Oral Tablet [SCD]23PRANDIN ® (repaglinide) Tablets (0.5, 1, and 2 mg)20150506
7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665repaglinide 2 MG Oral Tablet [PSN] · repaglinide 2 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720250915
d85abce4-16da-4231-b28a-6afca04ebf68repaglinide 2 MG Oral Tablet [PSN] · repaglinide 2 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720250605
cb995e92-295e-4638-a064-978211f5afe1repaglinide 2 MG Oral Tablet [PSN] · repaglinide 2 MG Oral Tablet [SCD]21REPAGLINIDE TABLETS These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720250502
7a93246c-9323-40c4-b590-a40dcb133c8crepaglinide 2 MG Oral Tablet [PSN] · repaglinide 2 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use REPAGLINIDE TABLETS safely and effectively. See full prescribing information for REPAGLINIDE TABLETS. REPAGLINIDE tablets, for oral use Initial U.S. Approval: 199720230404